Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹49,189Qualified | L1 | Qualified MSE, Category: General | |
| 2 | L2₹49,993.05+₹804.05 (1.63%)Qualified | L2 | Qualified MSE, Category: General | |
| 3 | L3₹50,833+₹1,644 (3.34%)Qualified | L3 | Qualified |
Tender Value
₹50,000
EMD Value
Exempted
Closing Date
25 Aug 2023, 1:00 pmClosed
Title
5182195
GEM/2023/B/3830210
Two Packet Bid
Title1,Title2,Title3,Title4,Title5,Title6,Title7,Title8,Title9,Title10,Title11,Title12,Title13,Titl
10 days
Ladakh; Leh Ladakh
Total value wise evaluation
BOQ
2 documents required · 2 mandatory
3 yrs
50%
Exempted
25 Aug 2023
15 Aug 2023
25 Aug 2023
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | Title1 | Inj Metronidazole IV 100ml | 150 | Bott | Leh | 10 |
| 2 | Title2 | Inj Paracetamol IV 100ml | 30 | Bott | Leh | 10 |
| 3 | Title3 | Inj Tonophosphon 100ml | 20 | Bott | Leh | 10 |
| 4 | Title4 | Inj Avil 30 ml | 50 | Vial | Leh | 10 |
| 5 | Title5 | Inj Dexamethasone 30ml | 50 | Vial | Leh | 10 |
| 6 | Title6 | Pulv Liv 52-100gm | 50 | Pkt | Leh | 10 |
| 7 | Title7 | Inj Enrofloxacin 100ml | 20 | Vial | Leh | 10 |
| 8 | Title8 | Inj Ranitidine | 200 | Amp | Leh | 10 |
| 9 | Title9 | Inj Belamyl 10ml | 50 | Vial | Leh | 10 |
| 10 | Title10 | Inj Vetalog 5 ml | 30 | Vial | Leh | 10 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_5182195.pdf
GEM_BID
help_file_2023-08-15-12-21-34_45757c259635839254c1e3d37701e4a1.pdf
BOQ
boq_item_sample_file_2023-08-15-12-21-34_616a6384d24416e60a1cd7db0c54a557.csv
BOQ
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .